ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 134 filers reported holding ANAPTYSBIO INC in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $650,000 | -90.3% | 25,465 | -72.2% | 0.01% | -97.8% |
| Q1 2019 | $6,691,000 | +75.7% | 91,600 | +53.4% | 0.23% | +58.9% |
| Q4 2018 | $3,808,000 | -3.9% | 59,700 | +50.4% | 0.15% | -17.0% |
| Q3 2018 | $3,961,000 | +878.0% | 39,700 | +596.5% | 0.18% | +700.0% |
| Q2 2018 | $405,000 | -44.2% | 5,700 | -18.3% | 0.02% | -59.3% |
| Q1 2018 | $726,000 | – | 6,975 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |